IBM Watson, Quest Diagnostics, Memorial Sloan Kettering partner for cancer research

Listen
Text
  • Small
  • Medium
  • Large

IBM Watson is teaming up with Quest Diagnostics and New York City-based Memorial Sloan Kettering Cancer Center to launch a new service: Watson Genomics from Quest Diagnostics, according to Fortune.

Through the service, physicians will be able to send a patient's tumor tissue to Quest Diagnostics for genetic sequencing. IBM Watson will then analyze the genetic alterations in the tissue, and Memorial Sloan Kettering will conduct a research-based analysis through its oncology precision medicine database to determine potential treatment options.

Through the collaboration, the partners hope to give physicians "the ability to create a unique, personalized approach for their patients," according to IBM.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars